FIELD: medicine.
SUBSTANCE: fresh-frozen plasma is unfrozen and centrifuged; the produced cryoprecipitate is solubilised and treated with aluminium hydroxide; the produced suspension is centrifuged; the produced deposit containing non-target proteins are rejected; the supernatant is treated with polyethylene glycol; the suspension is centrifuged; the supernatant is rejected; the deposit is solubilised and subject to viral inactivation, cleaned from viral inactivation products by shaking with Vaseline oil and re-precipitating with glycerol; the deposit procedure is repeated twice; the produced fibrinogen solution is bottled and lyophilised.
EFFECT: producing fibrinogen, which possesses fast solubility.
2 ex, 2 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF OBTAINING FIBRINOGEN CONCENTRATE | 2013 |
|
RU2556804C2 |
| METHOD OF PREPARING BIOLOGICAL ADHESIVE MADE OF CONCENTRATED COAGULATING FACTORS BY SALTING OUT | 1994 |
|
RU2130946C1 |
| ORGAN-SPECIFIC REGENERANT GI | 2011 |
|
RU2462255C1 |
| METHOD OF PRODUCING THROMBIN CONCENTRATE | 2014 |
|
RU2583931C2 |
| METHOD OF SEALING INTERINTESTINAL ANASTOMOSIS | 2011 |
|
RU2464942C1 |
| METHOD FOR PRODUCING CONCENTRATED FACTOR VIII OF HUMAN BLOOD PLASMA | 2010 |
|
RU2445974C2 |
| METHOD OF PRODUCING FIBRINOGEN USING STRONG ANION EXCHANGE RESIN AND FIBRINOGEN-CONTAINING PRODUCT | 2011 |
|
RU2603103C2 |
| METHOD OF PREPARATION OF AUTOLOGOUS TWO-COMPONENT FIBRIN ADHESIVE | 2019 |
|
RU2704256C1 |
| HAEMOSTATIC SPONGE AND METHOD FOR ITS PREPARATION | 2016 |
|
RU2618896C1 |
| HEMOSTATIC SPONGE AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2628809C1 |
